nad has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramov, AY; Angelova, PR; Barilani, M; Dossena, M; Gandhi, S; Lazzari, L; Lovejoy, C; Pezzoli, G; Piga, D; Seresini, A; Viganò, M | 1 |
| Abdin, AA; Hamouda, HE | 1 |
| Baudry, M; Fonck, C | 1 |
3 other study(ies) available for nad and Parkinsonian Disorders
| Article | Year |
|---|---|
Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.
Topics: Cell Differentiation; Cells, Cultured; Humans; Membrane Potential, Mitochondrial; Mesenchymal Stem Cells; Mitochondria; Mitophagy; NAD; Oxidative Stress; Parkinsonian Disorders; Reactive Oxygen Species; Supranuclear Palsy, Progressive | 2018 |
Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Levodopa; Mitochondria; NAD; Neurons; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Rats; Rotenone; Spectrophotometry; Ubiquinone; Ultrasonography; Vitamins | 2008 |
Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell Differentiation; Cell Survival; Dopamine; Dopamine Agents; Drug Interactions; Free Radical Scavengers; Herbicides; Lipid Peroxidation; NAD; Nerve Growth Factor; Neurons; Oxidopamine; Parkinsonian Disorders; PC12 Cells; Rats; Reactive Oxygen Species; Substantia Nigra; Tritium | 2001 |